Home  /  Resource Library  /  Early Epcoritamab Administration Revives CAR-T Cells in Relapsed/Refractory B-Cell Lymphomas

Early Epcoritamab Administration Revives CAR-T Cells in Relapsed/Refractory B-Cell Lymphomas

Study investigated effect of epcoritamab on CAR-T therapy in treatment of B-cell lymphomas.